These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35358639)

  • 1. Epicardial adipose tissue volume is an independent predictor of left ventricular reverse remodeling in patients with non-ischemic cardiomyopathy.
    Yamaguchi Y; Shibata A; Yoshida T; Tanihata A; Hayashi H; Kitada R; Ehara S; Izumiya Y; Fukuda D
    Int J Cardiol; 2022 Jun; 356():60-65. PubMed ID: 35358639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of body composition in left ventricular remodeling, reverse remodeling, and clinical outcomes for heart failure with mildly reduced ejection fraction: more knowledge to the "obesity paradox".
    Fu K; Dong Y; Wang Z; Teng J; Cheng C; Su C; Ji X; Lu H
    Cardiovasc Diabetol; 2024 Sep; 23(1):334. PubMed ID: 39261931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial conduit strain derived from cardiac magnetic resonance is an independent predictor of left ventricular reverse remodeling in patients with nonischemic cardiomyopathy.
    Chen K; Chang L; Huang R; Wang Z; Mu D; Wang L
    BMC Med Imaging; 2024 Jan; 24(1):2. PubMed ID: 38166678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of left ventricular hypertrabeculation is associated with improvement in systolic function and favorable prognosis in adult patients with non-ischemic cardiomyopathy.
    Minamisawa M; Koyama J; Kozuka A; Miura T; Ebisawa S; Motoki H; Okada A; Izawa A; Ikeda U
    J Cardiol; 2016 Nov; 68(5):431-438. PubMed ID: 26740463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of left ventricular reverse remodeling after catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction.
    Okada M; Tanaka N; Oka T; Tanaka K; Ninomiya Y; Hirao Y; Yoshimoto I; Inoue H; Kitagaki R; Onishi T; Koyama Y; Okamura A; Iwakura K; Sakata Y; Fujii K; Inoue K
    J Cardiol; 2021 May; 77(5):500-508. PubMed ID: 33272779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential predictive value of cardiac mechanics for left ventricular reverse remodelling in dilated cardiomyopathy.
    Kan A; Fang Q; Li S; Liu W; Tao X; Huang K; Hu M; Feng Z; Gong L
    ESC Heart Fail; 2023 Dec; 10(6):3340-3351. PubMed ID: 37697922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Iida Y; Iwamoto-Ishida M; Nabeta T; Ishii S; Sato T; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Nishii M; Ako J
    Heart Vessels; 2016 Apr; 31(4):545-54. PubMed ID: 25686768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Dose β-Blocker Therapy Triggers Additional Reverse Remodeling in Patients With Idiopathic Non-Ischemic Cardiomyopathy.
    Nitta D; Kinugawa K; Imamura T; Kato NP; Komuro I
    Int Heart J; 2016 Dec; 57(6):717-724. PubMed ID: 27818482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Effect of Pulmonary Artery Diameter/Ascending Aorta Diameter Ratio on Left Ventricular Reverse Remodeling in Patients With Dilated Cardiomyopathy.
    Shibata N; Hiraiwa H; Kazama S; Kimura Y; Araki T; Mizutani T; Oishi H; Kuwayama T; Kondo T; Morimoto R; Okumura T; Murohara T
    Circ J; 2022 Jun; 86(7):1102-1112. PubMed ID: 35082187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early vs. late reverse ventricular remodeling in patients with cardiomyopathy.
    Banno A; Kohsaka S; Inohara T; Koide K; Shiraishi Y; Kohno T; Sano M; Yoshikawa T; Fukuda K
    J Cardiol; 2016 Jul; 68(1):57-63. PubMed ID: 26362590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial Tissue Reverse Remodeling After Guideline-Directed Medical Therapy in Idiopathic Dilated Cardiomyopathy.
    Xu Y; Li W; Wan K; Liang Y; Jiang X; Wang J; Mui D; Li Y; Tang S; Guo J; Guo X; Liu X; Sun J; Zhang Q; Han Y; Chen Y
    Circ Heart Fail; 2021 Jan; 14(1):e007944. PubMed ID: 33185117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High body mass index is a predictor of left ventricular reverse remodelling in heart failure with reduced ejection fraction.
    Cescau A; Van Aelst LNL; Baudet M; Cohen Solal A; Logeart D
    ESC Heart Fail; 2017 Nov; 4(4):686-689. PubMed ID: 28752617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathy.
    Merlo M; Masè M; Vitrella G; Belgrano M; Faganello G; Di Giusto F; Boscutti A; Gobbo M; Gigli M; Altinier A; Lesizza P; Barbati G; Ramani F; De Luca A; Morea G; Cova MA; Stolfo D; Sinagra G
    Am J Cardiol; 2018 Aug; 122(3):490-497. PubMed ID: 29958711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy.
    Verdonschot JAJ; Hazebroek MR; Wang P; Sanders-van Wijk S; Merken JJ; Adriaansen YA; van den Wijngaard A; Krapels IPC; Brunner-La Rocca HP; Brunner HG; Heymans SRB
    Circ Heart Fail; 2018 Nov; 11(11):e005220. PubMed ID: 30571196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does left ventricular reverse remodeling influence long-term outcomes in patients with Chagas cardiomyopathy?
    Nakazone MA; Otaviano AP; Machado MN; Bestetti RB
    Cardiol J; 2022; 29(1):44-52. PubMed ID: 32207838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and prognosis implications of long term left ventricular reverse remodeling in patients with dilated cardiomyopathy.
    Ruiz-Zamora I; Rodriguez-Capitan J; Guerrero-Molina A; Morcillo-Hidalgo L; Rodriguez-Bailon I; Gomez-Doblas JJ; de Teresa-Galvan E; Garcia-Pinilla JM
    Int J Cardiol; 2016 Jan; 203():1114-21. PubMed ID: 26651150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy.
    Kubanek M; Sramko M; Maluskova J; Kautznerova D; Weichet J; Lupinek P; Vrbska J; Malek I; Kautzner J
    J Am Coll Cardiol; 2013 Jan; 61(1):54-63. PubMed ID: 23287372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, predictors and prognosis of ventricular reverse remodeling in idiopathic dilated cardiomyopathy.
    Amorim S; Campelo M; Martins E; Moura B; Sousa A; Pinho T; Silva-Cardoso J; Maciel MJ
    Rev Port Cardiol; 2016 May; 35(5):253-60. PubMed ID: 27118094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of endomyocardial biopsy in conjunction with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling in idiopathic dilated cardiomyopathy.
    Ishii S; Inomata T; Fujita T; Iida Y; Ikeda Y; Nabeta T; Yanagisawa T; Naruke T; Mizutani T; Koitabashi T; Takeuchi I; Ako J
    Heart Vessels; 2016 Dec; 31(12):1960-1968. PubMed ID: 26920939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relations between circulating and myocardial fibrosis-linked microRNAs with left ventricular reverse remodeling in dilated cardiomyopathy.
    Dziewięcka E; Totoń-Żurańska J; Wołkow P; Kołton-Wróż M; Pitera E; Wiśniowska-Śmiałek S; Khachatryan L; Karabinowska A; Szymonowicz M; Podolec P; Rubiś P
    Adv Clin Exp Med; 2020 Mar; 29(3):285-293. PubMed ID: 32207584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.